Characteristics, treatment patterns, and biomarker testing of patients with advanced RET fusion-positive non-small cell lung cancer in a real-world multi-country observational study: a brief report

Results of this real-world study provide insights into clinical characteristics, biomarker testing, and treatment patterns of patients with <i>RET</i> fusion-positive aNSCLC and highlight the need for awareness and education to increase <i>RET</i> testing with the intent to treat with selective RET inhibitors when appropriate to optimize outcomes for patients.